Johnson & Johnson Unrecognized Tax Benefits, Interest on Income Taxes Accrued
Johnson & Johnson (JNJ) had Unrecognized Tax Benefits, Interest on Income Taxes Accrued of $336.00 million as of 2025-12-28, per its 10-K filed 2026-02-11.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued · last filed 2026-02-11
- 2025-12-28: Unrecognized Tax Benefits, Interest on Income Taxes Accrued $336.00M.
- 2024-12-29: Unrecognized Tax Benefits, Interest on Income Taxes Accrued $274.00M.
- 2024-09-29: Unrecognized Tax Benefits, Interest on Income Taxes Accrued $400.00M.
- 2024-06-30: Unrecognized Tax Benefits, Interest on Income Taxes Accrued $400.00M.
| Period end | Unrecognized Tax Benefits, Interest on Income Taxes Accrued | Unrecognized Tax Benefits, Interest on Income Taxes Accrued as first filed |
|---|---|---|
| 2025-12-28 | $336.00M 10-K · filed 2026-02-11 | |
| 2024-12-29 | $274.00M 10-K · filed 2026-02-11 | |
| 2024-09-29 | $400.00M 10-Q · filed 2024-10-23 | |
| 2024-06-30 | $400.00M 10-Q · filed 2024-07-25 | |
| 2023-12-31 | $264.00M 10-K · filed 2025-02-13 | |
| 2023-01-01 | $637.00M 10-K · filed 2024-02-16 | $651.00M 10-K · filed 2023-02-16 |
| 2022-01-02 | $512.00M 10-K · filed 2023-02-16 | |
| 2021-01-03 | $468.00M 10-K · filed 2022-02-17 | |
| 2019-12-29 | $559.00M 10-K · filed 2021-02-22 | |
| 2018-12-30 | $503.00M 10-K · filed 2020-02-18 | |
| 2017-12-31 | $436.00M 10-K · filed 2019-02-20 | |
| 2017-01-01 | $344.00M 10-K · filed 2018-02-21 | |
| 2016-01-03 | $366.00M 10-K · filed 2017-02-27 | |
| 2014-12-28 | $298.00M 10-K · filed 2016-02-24 | |
| 2013-12-29 | $412.00M 10-K · filed 2015-02-24 | |
| 2012-12-30 | $422.00M 10-K · filed 2014-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ELI LILLY & Co (LLY) | United States | $1,113.804B | 42.28 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |